Literature DB >> 1940636

Beta-VLDL increases endothelial cell plasma membrane cholesterol.

J A Kim1, K Maxwell, D P Hajjar, J A Berliner.   

Abstract

In this study, the distribution of free cholesterol in cholesterol-loaded endothelial cells was examined. For these studies, cell fractionation methods were used to assess marker enzyme activity and cholesterol distribution. Treatment of rabbit aortic endothelial cells for 3 days with 50 micrograms/ml of beta-very low density lipoprotein (beta-VLDL) or malondialdehyde-low density lipoprotein (MDA-LDL) but not LDL caused a 50-100% increase in total cell unesterified cholesterol. The accumulation of free rather than esterified cholesterol in endothelial cells may be due to the ratio of hydrolysis to esterification, which we have shown in this study to be 10-fold higher in endothelial cells than in smooth muscle cells. This free cholesterol is found in the fractions enriched in plasma membrane markers and, to a lesser extent, in the Golgi-enriched fractions. The amount of cholesterol per mg of protein was increased approximately 50% in these fractions from cells treated for 3 days with 50 micrograms/ml of beta-VLDL. These increases in cholesterol content were reversible upon incubation of cells for 3 days in medium containing 15% fetal bovine serum. Alterations in several membrane functions were also observed in cholesterol-loaded cells. The activity of alkaline phosphatase, an enzyme marker for plasma membranes, was decreased by 25% and an alteration in membrane-associated microfilaments was seen with phalloidin staining. This morphological change in microfilaments was reflected in a decrease in filament ends as shown by cytochalasin binding and occurred without a change in total actin or vinculin. These microfilament changes were reversible.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940636

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Omega-3 fatty acids, membrane remodeling and cancer prevention.

Authors:  Natividad R Fuentes; Eunjoo Kim; Yang-Yi Fan; Robert S Chapkin
Journal:  Mol Aspects Med       Date:  2018-04-12

2.  Direct visualization of the arterial wall water permeability barrier using CARS microscopy.

Authors:  Bertrand M Lucotte; Chloe Powell; Jay R Knutson; Christian A Combs; Daniela Malide; Zu-Xi Yu; Mark Knepper; Keval D Patel; Anna Pielach; Errin Johnson; Lyudmyla Borysova; Kim A Dora; Robert S Balaban
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

3.  Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells.

Authors:  I Levitan; A E Christian; T N Tulenko; G H Rothblat
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

4.  Angiotensin II impairs endothelial nitric-oxide synthase bioavailability under free cholesterol-enriched conditions via intracellular free cholesterol-rich membrane microdomains.

Authors:  Eisuke Amiya; Masafumi Watanabe; Norihiko Takeda; Tetsuya Saito; Taro Shiga; Yumiko Hosoya; Tomoko Nakao; Yasushi Imai; Ichiro Manabe; Ryozo Nagai; Issei Komuro; Koji Maemura
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

5.  Cholesterol inhibits M-type K+ channels via protein kinase C-dependent phosphorylation in sympathetic neurons.

Authors:  Seul-Yi Lee; Hyun-Kyung Choi; Seong-Tae Kim; Sungkwon Chung; Myoung Kyu Park; Jung-Hwa Cho; Won-Kyung Ho; Hana Cho
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

Review 6.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06

Review 7.  Cholesterol and Kir channels.

Authors:  Irena Levitan
Journal:  IUBMB Life       Date:  2009-08       Impact factor: 3.885

8.  Interaction of hyperlipidemia and reactive oxygen species: Insights from the lipid-raft platform.

Authors:  Eisuke Amiya
Journal:  World J Cardiol       Date:  2016-12-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.